Stress Ventricular Function in Evaluating Patients With Pulmonary Hypertension

Dyspnea Clinical Trial

Official title:

Using the Stress Ventricular Function Assessment to Evaluate the Long-term Prognosis and Treatment Outcome in Patients With Pulmonary Hypertension

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02647034
• Other study ID #: 200905040R
• Status: Recruiting
• Phase: N/A
• First received: December 29, 2015
• Last updated: January 4, 2016
• Start date: July 2009
• Est. completion date: December 2018

Study information

• Verified date: January 2016
• Source: National Taiwan University Hospital
• Contact: Mei-Fang Cheng, M.D.
• Phone: 886-2-23123456
• Email: meifang[@]ntuh.gov.tw
• Is FDA regulated: No
• Health authority: Taiwan: Ministry of Health and Welfare
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This study investigated clinical parameters, laboratory data, imaging studies to evaluate patients with suspected pulmonary hypertension.

Description:

Left and right ventricular ejection fraction (LV/RV EF) at rest and immediately after exercise treadmill test (ETT) were measured by nuclear medicine study in consecutively symptomatic patients with suspected pulmonary hypertension, along with other clinical variables were correlated with right heart catheterization parameters.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 300
• Est. completion date: December 2018
• Est. primary completion date: December 2018
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients suspicious for pulmonary hypertension.

Exclusion Criteria:

• pregnant, lactating, CAD history

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Dyspnea
• Hypertension, Pulmonary

Intervention

Other:
• no intervention
no intervention

Locations

Country	Name	City	State
Taiwan	National Taiwan University Hospital and National Taiwan University College of Medicine	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	All-cause mortality		an average of 1 year	No